Repro Med Systems Stock Analysis

Repro Stock Analysis Notes

About 57.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 0.08. Repro Med Systems had not issued any dividends in recent years. KORU Medical Systems, Inc. designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Chester, New York. Koru Medical operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 77 people. To find out more about Repro Med Systems contact Linda Tharby at 845-469-2042 or learn more at https://www.korumedical.com.

Repro Med Systems Investment Alerts

Repro Largest EPS Surprises

View All Earnings Estimates

Repro Med Environmental, Social, and Governance (ESG) Scores

Repro Stock Institutional Investors

Note, although Repro Med's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Repro Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 202.43 M.

Repro Profitablity

The company has Profit Margin (PM) of (0.09) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.08) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.08.

Management Efficiency

Repro Med Systems has return on total asset (ROA) of (0.0921) % which means that it has lost $0.0921 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2171) %, meaning that it created substantial loss on money invested by shareholders. Repro Med's management efficiency ratios could be used to measure how well Repro Med manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to -0.25. The current year's Return On Capital Employed is expected to grow to -0.28. At present, Repro Med's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 23.1 M, whereas Other Current Assets are forecasted to decline to about 528.4 K.

Technical Drivers

As of the 14th of February 2026, Repro Med holds the Risk Adjusted Performance of 0.0772, coefficient of variation of 1166.02, and Semi Deviation of 2.95. Repro Med Systems technical analysis gives you tools to exploit past prices in attempt to determine a pattern that determines the direction of the company's future prices. Please check Repro Med Systems treynor ratio, as well as the relationship between the downside variance and kurtosis to decide if Repro Med Systems is priced some-what accurately, providing market reflects its current price of 4.67 per share. Given that Repro Med has jensen alpha of 0.3016, we recommend you to check out Repro Med Systems's recent market performance to make sure the company can sustain itself at a future point.

Repro Med Systems Price Movement Analysis

Repro Med Systems Insider Trading Activities

Repro Med Outstanding Bonds

Repro Med Predictive Daily Indicators

Repro Med Forecast Models

Repro Med's time-series forecasting models are one of many Repro Med's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Repro Med's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Repro Med Bond Ratings

Repro Med Systems financial ratings play a critical role in determining how much Repro Med have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Repro Med's borrowing costs.

Repro Med Systems Debt to Cash Allocation

Repro Med Systems currently holds 3.99 M in liabilities with Debt to Equity (D/E) ratio of 0.14, which may suggest the company is not taking enough advantage from borrowing. Repro Med Systems has a current ratio of 5.29, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Repro Med's use of debt, we should always consider it together with its cash and equity.

Repro Med Total Assets Over Time

Repro Med Assets Financed by Debt

The debt-to-assets ratio shows the degree to which Repro Med uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

Repro Med Debt Ratio

33.0

It looks as if about 67% of Repro Med's assets are financed through equity. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Repro Med's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Repro Med, which in turn will lower the firm's financial flexibility.

Repro Med Corporate Bonds Issued

Repro Short Long Term Debt Total

Stock analysis is the technique used by a trader or investor to examine and evaluate how Repro Med prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Repro shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Repro Med. By using and applying Repro Stock analysis, traders can create a robust methodology for identifying Repro entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Repro analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Repro analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Repro Med Systems stock analysis indicators help investors evaluate how Repro Med stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Repro Med shares will generate the highest return on investment. By understating and applying Repro Med stock analysis, traders can identify Repro Med position entry and exit signals to maximize returns.

When running Repro Med's price analysis, check to measure Repro Med's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Repro Med is operating at the current time. Most of Repro Med's value examination focuses on studying past and present price action to predict the probability of Repro Med's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Repro Med's price. Additionally, you may evaluate how the addition of Repro Med to your portfolios can decrease your overall portfolio volatility.